Shivani Karthikeyan

Shivani practices all aspects of U.S. patent law, with an emphasis on litigation, client counseling, and transactional matters. Her technical experience focuses on the life sciences, including biotechnology and pharmaceuticals.

Shivani represents brand-name innovators in Branded Hatch-Waxman (ANDA) pharmaceutical patent litigation and advises clients on patent and Food and Drug Administration (FDA) regulatory issues. She has significant experience supporting life sciences transactions, including due diligence, licensing agreements, and other IP-related transactions. Shivani has authored articles on topics related to IP and life sciences transactions, including license agreement drafting, retroactive sublicensing, and implied licenses by estoppel.

Shivani began her legal career at Finnegan as a summer associate and law clerk, where she conducted legal research and composed memoranda across a range of technical areas. She supported litigation and IP due diligence matters, and contributed to a book chapter on Biologics Price Competition and Innovation Act (BPCIA) litigation.

During law school, Shivani interned for the Honorable Kara Stoll at the CAFC, where she drafted research and bench memoranda, assisted with opinion writing, and attended oral arguments. Shivani also interned in the Office of Unfair Import Investigations (OUII) at the ITC, where she conducted research on various topics in ITC practice and drafted an institution memorandum. As an IP intern at a large pharmaceutical company, she conducted landscape analyses, research, and presented on FDA regulations and biotechnology patents. 

Shivani served as president of The George Washington University Law School’s Student Intellectual Property Law Association (SIPLA). She was also a member of her law school’s Moot Court Board and the American Intellectual Property Law Association (AIPLA) Quarterly Journal. Shivani places high value on giving back to those in need whenever possible and prioritizes maintaining a robust pro bono practice.